Oskar Kalb is the Head of Process R&D Drug Product for Small Molecules at Hoffmann-La Roche, where they focus on optimizing and up-scaling manufacturing processes. Previously, Oskar held leadership roles at Novartis, including Technology Platform Leader in Pharmaceutical and Analytical Development and Head of the Special Delivery Systems Group. They also served as Head of Formulation R&D for Oral Dosage Forms at Hoffmann-La Roche. Oskar earned a PhD in Pharmacy and Pharmaceutical Technology from Johannes Gutenberg-Universität Mainz, where they also completed their pharmacy education.
This person is not in the org chart
This person is not in any teams
This person is not in any offices